Blog / Archives
Collateral Damage from Illumina (ILMN) Warning: Looking For New Buys
11/21/11 The diagnostics and tools sector remain weak trading down about 1.9% slightly better than NASDAQ down 2.5%. Within the life sciences we prefer biopharmaceutical stocks because of M&A...
Investor Uprising – Guide to Biotech Investing
There is an excellent Guide to Biotech Investing on the Investor Uprising blog. You will need a IU account to view the document http://www.investoruprising.com/document.asp?doc_id=206689
Innovations Continue to Drive Market Gains
Over $50B in Product Sales Have Been Posted in the Last 20 Years as a Result of Biotech Advances Biotechnology stocks were up about 12% over the past 12 months through February 2011, underperforming...
Life Science Stocks Rally into the Third Day Up Over 2%
Risk is on for Life Science Stocks The rally that began late tuesday continued into the third day with major biotech indices up over 2%.The Rayno Life Science Portfolio was up 2.2% with recent...
Another Wild Day: Market Roars Back in Final 40 Minutes
Market Turns Up at 3:18 EDT for 2.28% Gain in S&P: 1080 is the mark for a 2011 bottom After a roller coaster day where stocks were ready to break the scary 1080 level on the S&P, it abruptly...
Sell-Off Breaks Through August 9 Technical Bottom: Biotechs Weak
Concerns About The Global Economy And Massive Debt Bring Us To Bear Market Boundaries The first day of the fourth quarter of 2011 held out hope for a new market direction, but the relentless selling...
Rally Rolls Over: Trading Range Intact-Biotech Outperforms in September
A 2.7+% rally faded today as European debt crisis headlines put a damper on optimism. Many of the pundits were skeptical of the rally saying it was driven by short covering. Biotechs Outperforming...
Nasty Day Reminds Us: The FED is Running Out of Juice
S&P Sells Off 2.94%-Caution Comes Back as Market is Down 4% in 3 Trading Days Something happened, but maybe we were just reminded that the economic picture is still grim and monetary policy has...
Healthcare Sector Gets Upgrade from Morgan Stanley
Biotechnology,Pharmaceuticals and Healthcare Providers Are Most Attractive After a five day rally led by chips, tech and industrials Morgan Stanley came out today calling the healthcare sector an...
European Rally Spills Over to US but Life Science Tools/DX Weak
A short term liquidity deal by the ECB to lend dollars to Euro-area banks has taken the heat off the sovereign debt crisis. For now.Many analysts however offer caution that the long term solvency...